Callery Corporation appoints Dr. Harry Rathore as CEO

Callery Corporation announced that it has appointed Dr. Harry Rathore as its Chief Executive Officer.

Dr. Rathore holds a Ph.D. in Medicinal Chemistry from the Oregon State University. He has over three decades of experience in leading innovative and highly-technical chemistry organizations in the pharmaceutical and specialty chemical sectors. Early in his career, he founded pharma chemical company, Polyorganix which was later acquired by Borregaard Synthesis, where he remained in an executive capacity for several years. His professional career also includes key executive roles at leading global companies, such as Lonza AG and Alcami Corporation. Previously, Dr. Rathore served as a board member of Borregaard Synthesis and Suven Life Sciences, and currently serves on the board of ZCL Chemicals.

Callery’s Board of Directors member, Bob Girton said that Harry has the perfect combination of industry knowledge, commercial experience and relationships, technical expertise, and a proven track record in leading innovative chemistry organizations. They are excited for the growth and success Harry and the Callery team will bring to the business. Callery is a great addition to their portfolio of performance materials companies with a common commercial theme of customer focus, technical service, and solution oriented sales.